A Prospective Non-Randomized Investigation Of The Use Of Infuse(R) (rhBMP-2) In Cervical Arthrodesis
Phase of Trial: Phase II
Latest Information Update: 17 Oct 2018
Price : $35 *
At a glance
- Drugs Dibotermin alfa (Primary)
- Indications Spinal disorders
- Focus Adverse reactions
- 09 Oct 2018 Status changed from active, no longer recruiting to completed.
- 31 Oct 2016 Status changed from recruiting to active, no longer recruiting.
- 30 Jul 2014 New trial record